CorMedix (CRMD) Current Deferred Revenue (2015 - 2019)
CorMedix (CRMD) posted Current Deferred Revenue of $2206.0 for Q4 2019, down 49.99% sequentially from $4411.0 in Q3 2019, and down 80.0% YoY from $11029.0 in Q4 2018.
CorMedix (CRMD) Current Deferred Revenue (2015 - 2019) Analysis & Trends
CorMedix has reported Current Deferred Revenue for 5 years, with the latest figure at $2206.0 in Q4 2019.
- Quarterly Current Deferred Revenue fell 80.0% year-over-year to $2206.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $2206.0 (down 80.0% YoY) and the FY2019 annual result came in at $2206.0, down 80.0% from the prior year.
- Current Deferred Revenue slipped to $2206.0 in Q4 2019 per CRMD's latest filing, from $4411.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $130409.0 in Q4 2015 and troughed at $2206.0 in Q4 2019.
- A 5-year average of $46141.4 and a median of $19870.0 in 2016 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2017 and 2018: Current Deferred Revenue surged 318.44% in 2017, then slumped 87.52% in 2018.
- Over 5 years, Current Deferred Revenue stood at $130409.0 in 2015, then declined by 20.09% to $104210.0 in 2016, then declined by 15.17% to $88404.0 in 2017, then plunged by 87.52% to $11029.0 in 2018, then plunged by 80.0% to $2206.0 in 2019.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $2206.0, $4411.0, and $6618.0 for Q4 2019, Q3 2019, and Q2 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 2,206.00 |
| Sep 30, 2019 | 4,411.00 |
| Jun 30, 2019 | 6,618.00 |
| Mar 31, 2019 | 8,800.00 |
| Dec 31, 2018 | 11,029.00 |
| Sep 30, 2018 | 13,200.00 |
| Jun 30, 2018 | 15,400.00 |
| Mar 31, 2018 | 17,647.00 |
| Dec 31, 2017 | 88,404.00 |
| Sep 30, 2017 | 86,600.00 |
| Jun 30, 2017 | 101,886.00 |
| Mar 31, 2017 | 101,000.00 |
| Dec 31, 2016 | 104,210.00 |
| Sep 30, 2016 | 22,093.00 |
| Jun 30, 2016 | 24,349.00 |
| Dec 31, 2015 | 130,409.00 |